A detailed history of Rice Hall James & Associates, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 6,555 shares of EW stock, worth $490,379. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,555
Previous 6,705 2.24%
Holding current value
$490,379
Previous $619,000 30.21%
% of portfolio
0.03%
Previous 0.04%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$59.7 - $93.78 $8,955 - $14,067
-150 Reduced 2.24%
6,555 $432,000
Q2 2024

Aug 07, 2024

SELL
$84.3 - $94.31 $9,525 - $10,657
-113 Reduced 1.66%
6,705 $619,000
Q1 2024

Apr 23, 2024

SELL
$72.54 - $95.56 $350,440 - $461,650
-4,831 Reduced 41.47%
6,818 $651,000
Q2 2023

Jul 24, 2023

SELL
$81.41 - $94.33 $661,700 - $766,714
-8,128 Reduced 41.1%
11,649 $1.1 Million
Q1 2023

May 11, 2023

SELL
$74.26 - $84.51 $16,262 - $18,507
-219 Reduced 1.1%
19,777 $1.64 Million
Q4 2022

Jan 27, 2023

SELL
$68.3 - $87.44 $288,499 - $369,346
-4,224 Reduced 17.44%
19,996 $0
Q3 2022

Nov 01, 2022

SELL
$82.37 - $107.29 $303,286 - $395,041
-3,682 Reduced 13.2%
24,220 $2 Million
Q2 2022

Aug 08, 2022

SELL
$86.5 - $128.27 $84,510 - $125,319
-977 Reduced 3.38%
27,902 $2.65 Million
Q1 2022

May 05, 2022

SELL
$101.96 - $128.34 $66,375 - $83,549
-651 Reduced 2.2%
28,879 $3.4 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $2,340 - $2,874
-22 Reduced 0.07%
29,530 $3.83 Million
Q3 2021

Nov 09, 2021

SELL
$102.91 - $122.75 $98,690 - $117,717
-959 Reduced 3.14%
29,552 $3.35 Million
Q2 2021

Jul 29, 2021

SELL
$83.84 - $104.76 $180,675 - $225,757
-2,155 Reduced 6.6%
30,511 $3.16 Million
Q1 2021

May 14, 2021

SELL
$78.68 - $90.67 $182,773 - $210,626
-2,323 Reduced 6.64%
32,666 $2.73 Million
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $466,056 - $593,086
-6,501 Reduced 15.67%
34,989 $3.19 Million
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $201,368 - $262,057
-2,997 Reduced 6.74%
41,490 $3.31 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $1.69 Million - $2.26 Million
29,377 Added 194.42%
44,487 $3.07 Million
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $192,606 - $297,675
-3,675 Reduced 19.56%
15,110 $2.85 Million
Q4 2019

Jan 29, 2020

SELL
$71.7 - $82.09 $9,177 - $10,507
-128 Reduced 0.68%
18,785 $4.38 Million
Q3 2019

Oct 30, 2019

SELL
$61.55 - $75.43 $82,846 - $101,528
-1,346 Reduced 6.64%
18,913 $4.16 Million
Q2 2019

Aug 01, 2019

SELL
$55.74 - $64.41 $12,764 - $14,749
-229 Reduced 1.12%
20,259 $3.74 Million
Q1 2019

May 01, 2019

SELL
$47.89 - $64.05 $20,401 - $27,285
-426 Reduced 2.04%
20,488 $3.92 Million
Q4 2018

Feb 14, 2019

SELL
$46.41 - $56.94 $3,944 - $4,839
-85 Reduced 0.4%
20,914 $3.2 Million
Q3 2018

Oct 25, 2018

SELL
$45.7 - $58.03 $5,621 - $7,137
-123 Reduced 0.58%
20,999 $3.66 Million
Q2 2018

Aug 02, 2018

SELL
$42.45 - $51.3 $18,932 - $22,879
-446 Reduced 2.07%
21,122 $3.08 Million
Q1 2018

Apr 25, 2018

SELL
$37.19 - $47.45 $5,206 - $6,643
-140 Reduced 0.64%
21,568 $3.01 Million
Q4 2017

Jan 23, 2018

SELL
$33.79 - $39.39 $93,327 - $108,795
-2,762 Reduced 11.29%
21,708 $2.45 Million
Q3 2017

Oct 30, 2017

BUY
$36.29 - $38.83 $888,016 - $950,170
24,470
24,470 $2.68 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.